EY-001
Diabetic Macular Edema
Phase 1Active
Key Facts
About EyeYon Medical
Israeli biotech delivering sustained‑release ocular implants for retinal disease therapy.
View full company profileTherapeutic Areas
Other Diabetic Macular Edema Drugs
| Drug | Company | Phase |
|---|---|---|
| Not Specified (Ophthalmology Program) | Therini Bio | Clinical-stage |
| OHB-401 | Oak Hill Bio | Pre-clinical |
| TAK-648 | Thermo Fisher Scientific | Phase 2 |
| AXPAXLI (OTX-TKI) | Ocular Therapeutix | Phase 3 |
| BGE-102 | BioAge Labs | Phase 1b/2a |
| 4D-150 | 4D Molecular Therapeutics | Phase 3 |